2014年4月15日
Successful treatment of acute kidney injury in patients with idiopathic nephrotic syndrome using human atrial natriuretic Peptide.
Internal medicine
- 巻
- 53
- 号
- 8
- 開始ページ
- 865
- 終了ページ
- 869
- 記述言語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.2169/internalmedicine.53.1724
- 出版者・発行元
- Japanese Society of Internal Medicine
The acute onset of idiopathic nephrotic syndrome (NS) is often accompanied by acute kidney injury, which can lead to congestive heart failure and lung edema. In this report, we present two cases of NS-induced acute kidney injury successfully treated with a low dose of carperitide, a human atrial natriuretic peptide. In combination with standard diuretic therapy and immunotherapy, carperitide retained the renal function and spared the need for renal replacement therapy, including hemodialysis. Although further investigation in clinical trials is required to validate these findings, carperitide may be useful for maintaining the renal function in cases of NS-induced acute kidney injury.
- リンク情報
- ID情報
-
- DOI : 10.2169/internalmedicine.53.1724
- ISSN : 0918-2918
- eISSN : 1349-7235
- ORCIDのPut Code : 59325419
- PubMed ID : 24739607